Kures
Dobbs Ferry
About Kures
Kures is a pre-clinical-stage biopharmaceutical startup that develops opioid-based treatments for depressive disorder. The biopharmaceutical company is also interested in addressing other challenging indications in the psychiatry and physical pain arena using its portfolio of novel small molecules. It is currently operating in Stealth mode. Andrew Kruegel established the biotech company in 2017 in Dobbs Ferry, New York.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.2M
- Last round: Series Unknown (Aug 2019)
- Website: kures.life
- Phone: (929) 265-7214
Industries & Categories
Alternative Medicine, Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kures-12994 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.